MAPT and Alzheimer disease: However, numerous studies have been shown that the most promising biomarkers for AD in CSF include the combined analysis of Aβ42, t-tatu and p-tau that allows sensitive, reliable and specific diagnosis of AD identifying prodromal AD in cases of MCI.